BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36280842)

  • 1. Metabolomic profile of prostate cancer-specific survival among 1812 Finnish men.
    Huang J; Zhao B; Weinstein SJ; Albanes D; Mondul AM
    BMC Med; 2022 Oct; 20(1):362. PubMed ID: 36280842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival.
    Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Mondul AM; Sampson JN; Albanes D
    J Gerontol A Biol Sci Med Sci; 2019 May; 74(6):853-859. PubMed ID: 29878065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.
    Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Liao LM; Gu F; Mondul AM; Sampson JN; Albanes D
    Am J Epidemiol; 2018 Aug; 187(8):1721-1732. PubMed ID: 29390044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
    Mondul AM; Sampson JN; Moore SC; Weinstein SJ; Evans AM; Karoly ED; Virtamo J; Albanes D
    Am J Clin Nutr; 2013 Aug; 98(2):488-93. PubMed ID: 23803886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted metabolomic profiling identifies serum metabolites associated with type 2 diabetes in a cross-sectional study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Liu Y; Gan L; Zhao B; Yu K; Wang Y; Männistö S; Weinstein SJ; Huang J; Albanes D
    Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E167-E175. PubMed ID: 36516224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
    Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
    Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.
    Watters JL; Gail MH; Weinstein SJ; Virtamo J; Albanes D
    Cancer Res; 2009 May; 69(9):3833-41. PubMed ID: 19383902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic analysis of serum alpha-tocopherol among men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Lawrence WR; Lim JE; Huang J; Sampson JN; Weinstein SJ; Albanes D
    Eur J Clin Nutr; 2022 Sep; 76(9):1254-1265. PubMed ID: 35322169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Profiling of Serum Retinol in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Huang J; Panagiotou OA; Anic GM; Mondul AM; Liao LM; Derkach A; Stolzenberg-Solomon R; Weinstein SJ; Albanes D
    Sci Rep; 2017 Sep; 7(1):10601. PubMed ID: 28878287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair dye use and prostate cancer risk: A prospective analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort.
    Lim JE; Huang J; Mӓnnistӧ S; Weinstein SJ; Albanes D
    Cancer; 2022 Mar; 128(6):1260-1266. PubMed ID: 34797564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
    Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
    J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Nelson SM; Panagiotou OA; Anic GM; Mondul AM; Männistö S; Weinstein SJ; Albanes D
    Int J Epidemiol; 2016 Oct; 45(5):1458-1468. PubMed ID: 27524818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.
    Wright ME; Albanes D; Moser AB; Weinstein SJ; Snyder K; Männistö S; Gann PH
    Cancer Med; 2014 Dec; 3(6):1562-9. PubMed ID: 25132681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Retinol and Risk of Overall and Site-Specific Cancer in the ATBC Study.
    Hada M; Mondul AM; Weinstein SJ; Albanes D
    Am J Epidemiol; 2020 Jun; 189(6):532-542. PubMed ID: 31612201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer.
    Wang Y; Jacobs EJ; Carter BD; Gapstur SM; Stevens VL
    Eur Urol Oncol; 2021 Feb; 4(1):56-65. PubMed ID: 31378665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications.
    Lyon DE; Yao Y; Garrett T; Kelly DL; Cousin L; Archer KJ
    BMC Womens Health; 2023 May; 23(1):221. PubMed ID: 37138260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.